Analyst Reco. Organon & Co.

Equities

OGN

US68622V1061

Market Closed - Nyse Other stock markets 01:30:02 30/04/2024 am IST			5-day change	1st Jan Change
18.9 ^USD	+1.89%		+5.00%	+31.07%

29/04	Piper Sandler Raiises Price Target on Organon to $24 From $22, Maintains Overweight Rating	MT
09/04	Morgan Stanley Lifts Price Target on Organon to $18 From $17, Keeps Equalweight Rating	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Piper Sandler Raiises Price Target on Organon to $24 From $22, Maintains Overweight Rating	29/04	MT
Morgan Stanley Lifts Price Target on Organon to $18 From $17, Keeps Equalweight Rating	09/04	MT
Goldman Sachs Adjusts Price Target on Organon to $18 From $16, Keeps Neutral Rating	20/02	MT
Piper Sandler Adjusts Organon & Co.'s Price Target to $22 From $32, Maintains Overweight Rating	22/11	MT
Goldman Sachs Downgrades Organon to Neutral From Buy, Cuts Price Target to $16 From $33	03/11	MT
Morgan Stanley Adjusts Price Target on Organon to $22 From $27, Maintains Equal-Weight Rating	11/23/11	MT
Barclays Initiates Organon With Overweight Rating, Price Target is $28	21/23/21	MT
Morgan Stanley Adjusts Price Target on Organon to $27 From $25, Maintains Equal-Weight Rating	09/23/09	MT
Morgan Stanley Cuts Price Target on Organon to $25 From $26, Maintains Equal-Weight Rating	08/23/08	MT
Raymond James Starts Organon & Co. at Outperform With $33 Price Target	16/23/16	MT
Hot Wholesale Prices Print Saps Appetite for US Equities as Concern Mounts Rates Headed Higher	16/23/16	MT
Marketmind: Growth trumps rates	16/23/16	RE
Morgan Stanley Lowers Price Target for Organon to $24 From $27, Keeps Equalweight Rating	04/22/04	MT
BofA Securities Downgrades Organon to Underperform From Neutral, Adjusts Price Target to $25 From $37	14/22/14	MT
Morgan Stanley Lowers Organon & Co's Price Target to $27 From $35, Maintains Equalweight Rating	12/22/12	MT
Piper Sandler Upgrades Organon & Co. to Overweight From Neutral, Adjusts Price Target to $34 From $37	06/22/06	MT
Goldman Sachs Trims Organon & Co's Price Target to $38 From $41, Keeps Buy Rating	08/22/08	MT
BofA Securities Downgrades Organon to Neutral From Buy, Adjusts Price Target to $37 From $40	05/22/05	MT
Goldman Sachs Adjusts Price Target for Organon & Co to $41 From $42, Maintains Buy Rating	19/22/19	MT
Morgan Stanley Trims Organon & Co's Price Target to $34 From $35, Maintains Equalweight Rating	08/22/08	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Organon & Co.

Equities

OGN

US68622V1061

Analyst Reco.

Filters